8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001628280-22-020108
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading cccc-20220729.htm…